Avalo Therapeutics, Inc. (AVTX)
NASDAQ·Healthcare·Biotechnology
$6.75
-0.22%
Mkt Cap $362.00M
Analyst Ratings
Buy
11
Hold
2
Sell
0
Price Target (14 analysts)
$45.13
Range $30.00 – $60.00
Implied Upside
+568.6%
Consensus $45.13 vs current $6.75
NASDAQ·Healthcare·Biotechnology
$6.75
-0.22%
Mkt Cap $362.00M
Buy
11
Hold
2
Sell
0
Price Target (14 analysts)
$45.13
Range $30.00 – $60.00
+568.6%
Consensus $45.13 vs current $6.75